← Back to Search

Topical Agent

ALX-101 Gel 5% for Atopic Dermatitis

Phase 2
Waitlist Available
Research Sponsored by Ralexar Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 57
Awards & highlights

Study Summary

This is a Phase 2, randomized, double-blind, vehicle-controlled, parallel-group study to evaluate the safety and efficacy of ALX-101 Gel 5% and a matching ALX-101 Gel Vehicle when applied topically twice daily for 56 days in adult and adolescent subjects with moderate atopic dermatitis

Eligible Conditions
  • Atopic Dermatitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 57
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 57 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Eczema Area Severity Index (EASI)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ALX-101 Gel 5%Experimental Treatment1 Intervention
ALX-101 Gel 5% applied topically twice daily for 56 days
Group II: ALX-101 Gel VehiclePlacebo Group1 Intervention
ALX-101 Gel Vehicle applied topically twice daily for 56 days

Find a Location

Who is running the clinical trial?

Ralexar Therapeutics, Inc.Lead Sponsor
1 Previous Clinical Trials
209 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study in Subjects With Moderate Atopic Dermatitis
2019. "Study in Subjects With Moderate Atopic Dermatitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03859986.
All > Seborrheic Dermatitis > Atopic Dermatitis
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top